Home›Psychiatry› Behavioral activation reduces depressive symptoms in at-risk adults, moderate effect at post-intervention
Behavioral activation reduces depressive symptoms in at-risk adults, moderate effect at post-interventionBehavioral activation helps reduce symptoms for people with depression
Journal of affective disordersPublished August 15, 2026Study authors: Rochelle Nathania Seanette, Hoyer JuergenPubMed ↗DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider behavioral activation as a preventive option for at-risk adults, but note limited long-term effect.
This meta-analysis synthesized data from 3213 at-risk adults, including older adults, caregivers, stroke patients, and students, to evaluate behavioral activation (BA) for depression prevention. BA involved activity scheduling and monitoring, compared with active or passive controls. The primary outcome was depressive symptoms at post-intervention, with secondary assessment at one-year follow-up.
At post-intervention, BA showed a significant moderate effect favoring the intervention (g = -0.56, 95% CI [-0.78, -0.33]), indicating a reduction in depressive symptoms. However, at one-year follow-up, the effect was small and non-significant (g = -0.31, 95% CI [-0.68, 0.07], p =.09).
The authors noted substantial heterogeneity (I² = 79.7%), borderline significant publication bias, and low evidence quality according to GRADE. Delivery method significantly moderated effects, whereas session number did not. Adverse events were not reported.
Despite the low robustness, BA appears to be an effective and lower-cost alternative for depression prevention. Clinicians should consider BA as a viable option, but the limited long-term effect and low certainty warrant cautious interpretation.
How this fits prior evidence
This meta-analysis extends prior coverage on depression prevention by showing that behavioral activation, a low-cost intervention, significantly reduces depressive symptoms in at-risk adults, complementing findings that exercise and mind-body training may reduce depressive symptoms in postmenopausal women. It also contrasts with the robust effects of prefrontal rTMS for MDD, as BA's effect was moderate and not sustained at one year. The findings address a gap by focusing on prevention in at-risk populations, whereas prior items addressed treatment or specific subgroups.
Living with depression can feel like being stuck in a heavy fog. For many people, including students, caregivers, and those recovering from strokes, finding an effective way to clear that fog is vital. New data suggests that behavioral activation might offer a helpful path forward.
Behavioral activation involves two main parts: scheduling specific activities and monitoring how they make you feel. Researchers looked at over 3,000 adults and found that this approach led to a moderate reduction in depressive symptoms immediately after the program ended. It is often seen as a lower-cost alternative for managing mental health.
While the initial results were positive, the evidence has some limits. The study showed only a small, non-significant change in symptoms one year later. Because of differences in how the programs were delivered and other factors, the overall quality of the evidence is considered low. Talk to your doctor to see if this approach fits your specific needs.
What this means for you:
Behavioral activation can reduce depression symptoms quickly, though its long-term effects are less certain.
Common questions
What is behavioral activation?
Behavioral activation is a method that involves two main parts: scheduling specific activities and monitoring your progress. It focuses on changing behaviors to improve mood. In this study of 3,213 adults, it was found to be an effective way to reduce depressive symptoms after the intervention.
How long do the results last?
The study showed a significant moderate effect on depressive symptoms immediately after the program. However, when looking at one-year follow-up data from 7 studies, the improvement was small and not statistically significant. This means the immediate impact is clearer than the long-term results.
Who can benefit from this approach?
The study included a wide range of at-risk adults. This includes older adults, caregivers, students, and people who have suffered a stroke. Because it is often lower-cost, it may be a practical option for many different groups of people seeking to manage depression.
OBJECTIVE: Cognitive-behavioral interventions are effective for depression prevention but face challenges with adherence and cost. This meta-analysis evaluated the effectiveness of behavioral activation (BA) in reducing depressive symptoms in selective and indicated prevention.
METHODS: We searched Scopus, PsycINFO, and MEDLINE, screening 2858 studies. RCTs applying core BA principles (activity scheduling and monitoring) in indicated or selective prevention were included. BA interventions were compared with active or passive controls. Random-effects meta-analysis was conducted, and subgroup analyses examined prevention indication, risk of bias, and number of sessions.
RESULTS: By January 2025, 23 RCTs (N = 3213) met inclusion criteria. Studies targeted older adults (n = 9), caregivers (n = 6), adults (n = 2), stroke patients (n = 1), and students (n = 1). Post-intervention analysis (k = 19) showed a significant moderate effect favoring BA (g = -0.56; 95% CI [-0.78, -0.33]). Exploratory analysis at one-year follow-up (k = 7) yielded a small, non-significant effect (g = -0.31; 95% CI [-0.68, 0.07], p = .09). Heterogeneity was substantial (I = 79.7%), and publication bias was borderline significant. Limited evidence was found for differences in risk of bias or prevention indication. Delivery method significantly moderated effects, whereas session number did not. According to GRADE, evidence quality was low.
CONCLUSIONS: BA appears to be an effective and lower-cost alternative for depression prevention, but the robustness of the findings is low. Hence, better quality studies are needed in other populations.
